2773 results found
NHMRC opened a Targeted Call for Research (TCR) into Participation in Cancer Screening Programs on 23 June 2021. Applications closed on 18 August 2021.
Professor Ben Howden, from the University of Melbourne at the Doherty Institute, is a renowned clinician researcher whose dedicated focus on public health microbiology, genomics and antimicrobial resistance (AMR) has impacted thousands of lives.
Professor Cath Chamberlain, a Palawa woman of the Trawlwoolway clan (Tasmania), received an NHMRC Early Career Fellowship in 2014 to find culturally safe ways to improve cardiometabolic health outcomes in Aboriginal and Torres Strait Islander mothers.
Less than 10% of adolescents globally, including in Australia, do enough physical activity to align with the amount required for young people to be healthy.
Preterm birth occurs in approximately 1 in 10 infants globally. It causes about three-quarters of near-birth deaths and more than half of newborn deaths.
It is well known that Aboriginal and Torres Strait Islander peoples’ conceptions of health and wellbeing and life experiences differ vastly from mainstream populations.
Not all orthopaedic implants are created equal. Surgeons repair bone fractures using metal plates and screws but sometimes the screws loosen and the surgery needs to be repeated. Previous expandable screws increased screw fixation strength but were more difficult (or impossible) to remove and increased surgery time.
When exposed to highly palatable (yummy) foods, some people overeat and have trouble regulating their intake long-term.
The 43rd biannual report
The National Health and Medical Research Council (NHMRC) has honoured the outstanding achievements with its annual Research Excellence Awards announced this evening in Canberra.
Proposals received through the Community Research Priorities Portal are assessed and prioritised by the TCR Prioritisation Committee using this rubric.
Consultation on options to reach gender equity in the Investigator Grant scheme: Consultation closed
NHMRC's vision is a gender diverse and inclusive health and medical research workforce to take advantage of the full range of talent needed to build a healthy Australia. NHMRC has completed its consultation on options to reach gender equity in the NHMRC Investigator Grant scheme.
The Privacy Legislation Amendment Act 2006 (Cth) made changes to the Privacy Act 1988(Cth) (the Privacy Act) to allow health practitioners to disclose patient’s genetic information, whether or not they give consent, in circumstances where there is reasonable belief that doing so is necessary to lessen or prevent a serious threat to the life, health or safety of their genetics relative(s). The amendments do not oblige disclosure of information but provide the framework for this to occur under the appropriate circumstances.
The Australian Government Department of Health and Aged Care (the department) and National Health and Medical Research Council (NHMRC) undertook consultation processes to provide an opportunity for members of the public, peak bodies, experts and other interested stakeholders to consider mitochondrial donation in the Australian context.
Influenza pandemics have caused death and social tragedy for hundreds of years, and the control of influenza was a priority for health and medical researchers in Australia during the twentieth century. From the 1930s to the 1960s, Frank Macfarlane Burnet and his team of NHMRC-funded researchers at The Walter and Eliza Hall Institute (WEHI) made major contributions to our understanding of the influenza virus and how to prevent and treat infection.
The Patient Blood Management Guidelines (the Guidelines) were developed following increasing evidence of transfusion-related adverse outcomes, leading to the emergence of new practices, including restrictive transfusion strategies and the increased use of alternatives to transfusion in the management of anaemia.
Haemolytic disease of the fetus and newborn (HDFN, also known as Rh Disease) can occur during pregnancy when a pregnant woman’s immune system produces antibodies that attack their fetus’ red blood cells (RBCs). Once a major cause of fetal and newborn mortality, today HDFN is almost non-existent in Australia due to routine antenatal blood grouping and antibody screening, and the use of prophylactic Rh D immunoglobulin and appropriate clinical management of mother and baby. Guidelines, initially produced by NHMRC on behalf of the Department of Health and Ageing, have assisted with translation of the research on Rh D antibody screening and Rh D immunoglobin into clinical practice.